Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana

Monoclonal antibodies are considered to be highly effective therapeutic tools for the treatment of mild to moderate COVID-19 patients. In the present work, we describe the production of two SARS-CoV-2 human IgG1 monoclonal antibodies recognizing the spike protein receptor-binding domain (RBD) and en...

Descripción completa

Detalles Bibliográficos
Autores principales: Frigerio, Rachele, Marusic, Carla, Villani, Maria Elena, Lico, Chiara, Capodicasa, Cristina, Andreano, Emanuele, Paciello, Ida, Rappuoli, Rino, Salzano, Anna Maria, Scaloni, Andrea, Baschieri, Selene, Donini, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Plant Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484322/
https://www.ncbi.nlm.nih.gov/pubmed/36131799
http://dx.doi.org/10.3389/fpls.2022.956741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484322/
https://www.ncbi.nlm.nih.gov/pubmed/36131799
http://dx.doi.org/10.3389/fpls.2022.956741

Ejemplares similares